3.85%C 7.22 11.94%GE 17.61 13.61%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
EXETER, N.H. - Bentley Pharmaceuticals Inc. said Thursday shareholders will receive a slightly lower price from purchaser Teva Pharmaceutical Industries Ltd. now that Bentley has spun off its drug delivery business, CPEX Pharmaceuticals.
Israel-based Teva agreed to buy Bentley for about $15.02 per share cash, or about $360 million, in March to boost its generic drug operations in Spain.
It is now offering about $14.82 per share cash for Bentley.
Shareholders are scheduled to vote on the agreement at a special meeting on July 22.
Bentley shares closed Thursday's abbreviated trading session down 3 cents at $14.75.
U.S. stocks made early gains on Tuesday, a day after the Dow Jones Industrial Average recorded its fourth-biggest point drop on record, as invest...
China markets opened lower on Tuesday morning as the investors' confidence hit by the signals that global recession are deepening.
Otto Spoerri, dubbed "the ultimate arbiter of industry power" because he determined seating at the Oscars, has died. He was 75. Spoerri died Satu...
Get your next web design project done with our los angeles web design team - Best web design with great price.
Building your business and corporate credit for your small business.
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
0.02
